US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 1.170
  • 0.0000.00%
Close Feb 14 16:00 ET
244.12MMarket Cap-1.65P/E (TTM)

Sangamo Therapeutics Key Stats

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 30.667M--
--2024/Q4-- / 11.700M--
Nov 12, 20242024/Q349.412M / 25.071M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 30.667M--
--2024/Q4-- / 11.700M--
Nov 12, 20242024/Q349.412M / 25.071M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More